Iradimed Income Statement (2013-2026) | IRMD

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	9.81M	10.91M	11.87M	12.31M	12.72M	13.41M	14.86M	15.48M	16.13M	16.50M	17.45M	17.60M	17.93M	18.33M	19.39M	19.51M	20.41M	21.20M	22.69M	21.98M
Cost of Revenue (Quarter)	2.48M	2.50M	2.33M	3.07M	2.58M	2.86M	3.67M	0.79M	3.94M	2.86M	6.59M	4.21M	3.48M	4.13M	5.79M	4.67M	4.45M	4.71M	4.60M	4.05M
Gross Profit (Quarter)	7.33M	8.41M	9.25M	9.38M	10.14M	10.54M	11.22M	11.72M	12.19M	12.84M	13.41M	13.39M	14.01M	14.19M	14.76M	14.84M	15.95M	16.49M	17.03M	16.81M
Operating items
Research & Development (Quarter)	0.45M	0.48M	0.49M	0.52M	0.66M	0.49M	0.60M	3.00M	0.96M	0.45M	0.65M	0.82M	0.80M	0.64M	0.57M	0.62M	0.88M	0.67M	0.80M	0.96M
Selling, General & Administrative (Quarter)	2.56M	2.25M	2.52M	2.72M	2.40M	2.88M	2.70M	3.92M	3.31M	3.62M	4.27M	3.99M	4.10M	3.97M	3.87M	4.61M	4.28M	4.36M	4.54M	4.57M
Other Operating Expenses (Quarter)	2.47M	2.59M	3.12M	3.07M	2.91M	3.04M	3.67M	0.79M	2.95M	2.86M	3.33M	3.83M	3.48M	3.80M	4.52M	4.18M	4.01M	4.63M	4.60M	4.05M
Operating Expenses (Quarter)	5.49M	5.32M	6.14M	6.30M	5.97M	6.41M	6.97M	7.71M	7.22M	6.93M	8.25M	8.64M	8.38M	8.40M	8.96M	9.41M	9.17M	9.66M	9.94M	9.58M
Operating Income (Quarter)	1.84M	3.09M	3.11M	3.07M	4.17M	4.13M	4.25M	4.01M	4.96M	5.91M	5.16M	4.75M	5.63M	5.79M	5.80M	5.43M	6.79M	6.83M	-13.10M	7.24M
EBIT (Quarter)	1.84M	3.09M	3.11M	3.07M	4.17M	4.13M	4.25M	4.01M	4.96M	5.91M	5.16M	4.75M	5.63M	5.79M	5.80M	5.43M	6.79M	6.83M	-13.10M	7.24M
Non-operating items
Non Operating Income (Quarter)	0.01M	0.01M	0.00M	-0.01M	0.01M	0.11M	0.45M	0.34M	0.34M	0.50M	0.52M	0.50M	0.64M	0.63M	0.54M	0.51M	0.54M	0.46M	0.70M	0.53M
Net income details
EBT (Quarter)	1.86M	3.09M	3.11M	3.06M	4.18M	4.24M	4.70M	4.35M	5.30M	6.41M	5.68M	5.24M	6.27M	6.42M	6.34M	5.95M	7.33M	7.30M	7.79M	7.77M
Tax Provisions (Quarter)	0.39M	0.52M	-0.78M	0.57M	0.94M	0.81M	1.03M	0.94M	1.12M	1.34M	2.56M	1.11M	1.37M	1.37M	1.20M	1.26M	1.55M	1.72M	1.35M	1.95M
Profit After Tax (Quarter)	1.47M	2.58M	3.89M	2.49M	3.24M	3.43M	3.67M	3.41M	4.18M	5.07M	4.54M	4.14M	4.90M	5.05M	5.15M	4.69M	5.77M	5.58M	6.44M	5.82M
Income from Continuing Operations (Quarter)	1.47M	2.58M	3.89M	2.49M	3.24M	3.43M	3.67M	3.41M	4.18M	5.07M	3.12M	4.14M	4.90M	5.05M	5.15M	4.69M	5.77M	5.58M	6.44M	5.82M
Consolidated Net Income (Quarter)	1.47M	2.58M	3.89M	2.49M	3.24M	3.43M	3.67M	3.41M	4.18M	5.07M	3.12M	4.14M	4.90M	5.05M	5.15M	4.69M	5.77M	5.58M	6.44M	5.82M
Income towards Parent Company (Quarter)	1.47M	2.58M	3.89M	2.49M	3.24M	3.43M	3.67M	3.41M	4.18M	5.07M	3.12M	4.14M	4.90M	5.05M	5.15M	4.69M	5.77M	5.58M	6.44M	5.82M
Net Income towards Common Stockholders (Quarter)	1.47M	2.58M	3.89M	2.49M	3.24M	3.43M	3.67M	3.41M	4.18M	5.07M	3.12M	4.14M	4.90M	5.05M	5.15M	4.69M	5.77M	5.58M	6.44M	5.82M
Additional items
EPS (Basic) (Quarter)	0.12	0.21	0.32	0.20	0.26	0.27	0.29	0.27	0.33	0.40	0.36	0.33	0.39	0.40	0.41	0.37	0.45	0.44	0.51	0.46
EPS (Weighted Average and Diluted) (Quarter)	0.12	0.20	0.31	0.20	0.26	0.27	0.30	0.27	0.33	0.40	0.36	0.32	0.38	0.40	0.40	0.37	0.45	0.43	0.50	0.45
Shares Outstanding (Weighted Average) (Quarter)	12.31M	12.32M	12.35M	12.55M	12.56M	12.56M	12.56M	12.59M	12.59M	12.60M	12.60M	12.66M	12.66M	12.67M	12.67M	12.71M	12.72M	12.72M	12.72M	12.78M
Shares Outstanding (Diluted Average) (Quarter)	12.54M	12.57M	12.59M	12.66M	12.63M	12.64M	12.64M	12.69M	12.72M	12.74M	12.72M	12.75M	12.76M	12.76M	12.78M	12.83M	12.84M	12.84M		12.87M
EBITDA (Quarter)	1.84M	3.09M	3.11M	3.07M	4.17M	4.13M	4.25M	4.01M	4.96M	5.91M	5.16M	4.75M	5.63M	5.79M	5.80M	5.43M	6.79M	6.83M	-13.10M	7.24M
Tax Rate (Quarter)	20.87%	16.73%	-25.03%	18.74%	22.46%	19.12%	21.90%	21.69%	21.11%	20.93%	45.13%	21.11%	21.82%	21.33%	18.87%	21.16%	21.20%	23.58%	17.31%	25.11%

Research Tools

Iradimed Income Statement (2013-2026) | IRMD

Create an account

Sign In

Reset Password